O'Shaughnessy Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.04M Buy
131,722
+975
+0.7% +$15.1K 0.01% 765
2025
Q1
$1.94M Buy
130,747
+41,192
+46% +$613K 0.02% 699
2024
Q4
$1.19M Sell
89,555
-14,628
-14% -$194K 0.01% 882
2024
Q3
$1.49M Buy
104,183
+41,875
+67% +$600K 0.01% 752
2024
Q2
$806K Sell
62,308
-26,355
-30% -$341K 0.01% 929
2024
Q1
$1.23M Buy
88,663
+26,735
+43% +$371K 0.01% 744
2023
Q4
$884K Sell
61,928
-20,561
-25% -$293K 0.01% 799
2023
Q3
$1.28M Buy
82,489
+8,671
+12% +$134K 0.02% 607
2023
Q2
$1.16M Buy
73,818
+4,729
+7% +$74.3K 0.02% 602
2023
Q1
$1.14M Sell
69,089
-64,930
-48% -$1.07M 0.02% 607
2022
Q4
$2.09M Sell
134,019
-20,364
-13% -$318K 0.03% 421
2022
Q3
$2M Sell
154,383
-7,214
-4% -$93.5K 0.04% 392
2022
Q2
$2.27M Sell
161,597
-33,561
-17% -$471K 0.04% 356
2022
Q1
$2.8M Buy
195,158
+94,217
+93% +$1.35M 0.05% 330
2021
Q4
$1.38M Sell
100,941
-9,787
-9% -$133K 0.02% 438
2021
Q3
$1.81M Buy
110,728
+57,621
+108% +$944K 0.04% 332
2021
Q2
$894K Buy
53,107
+20,184
+61% +$340K 0.02% 499
2021
Q1
$601K Buy
32,923
+9,852
+43% +$180K 0.01% 544
2020
Q4
$420K Sell
23,071
-846
-4% -$15.4K 0.01% 571
2020
Q3
$427K Buy
23,917
+1,705
+8% +$30.4K 0.01% 481
2020
Q2
$398K Buy
22,212
+18,067
+436% +$324K 0.01% 456
2020
Q1
$63K Sell
4,145
-2,235
-35% -$34K ﹤0.01% 730
2019
Q4
$126K Buy
6,380
+6,372
+79,650% +$126K ﹤0.01% 733
2019
Q3
$0 Buy
+8
New ﹤0.01% 1232